News | Oncology Analytics Launches MATIS™ Clinical Decision Support Software

Oncology Analytics Launches MATISTM Clinical Decision Support Software

New Centralized and Comprehensive Web-based Application Improves Usability, Efficiency and Productivity in Cancer Care Benefit Management

Oncology Analytics, Inc., today announced that its MATISTM clinical decision support software has launched, and is actively in use with health care plans and providers throughout the U.S. and Puerto Rico. MATISTM is designed to enhance Oncology Analytics’ evidence-based approach to the evaluation of cancer treatment and benefits management. MATISTM advantages include improving efficiencies and processing times to deliver timely and accurate responses to provider requests and to provide information on value-based treatment alternatives consistent with the highest standards of oncology care. To keep pace with the company’s growth, its existing, award-winning software application was upgraded using a stronger scalable core for best-in-class turnaround times with improved dashboards for provider usability.

The ability for MATISTM to give providers choices for their patients allows them to deliver the best oncology treatment with greater confidence at lower costs to the patient and health plan. Additionally, MATISTM enables providers to automatically confirm eligibility information at the time of authorization, populating all relevant fields with the most current information.

“The mission of Oncology Analytics is to assure that patients receive high-quality, cost-effective cancer care while minimizing administrative burdens for providers”, said Marc Fishman, MD, CEO and founder of Oncology Analytics, Inc. “MATISTM software helps us to achieve these goals while enhancing Oncology Analytics’ analytic capabilities.”

For more information on MATISTM software, or how Oncology Analytics can partner with your health plan to improve patient treatment choices while reducing costs and maintaining provider satisfaction, please contact Marisela Medrano at Oncology Analytics at 954-637-0787.

Plantation, Florida, August 15, 2016

About Oncology Analytics, Inc.

Founded in Plantation, Florida, in 2009, Oncology Analytics, Inc., accredited by URAC for Health Utilization Management, is a comprehensive oncology benefits management company serving health plans, providers and patients in the U.S. market and Puerto Rico. Oncology Analytics has continued its mission of using evidence-based medicine to drive better treatment options for cancer care at reduced costs. Using a patient-focused approach, Oncology Analytics’ clinical team of board-certified hematologists/oncologists, oncology RNs, and board-certified oncology pharmacists personally review individual cases that require additional assessment for individualized care.

Evidence Based. Results Driven. Patient Focused.

PRESS RELEASE
Contact:

Oncology Analytics, Inc.
Marisela Medrano
Director of Marketing & Sales
(954) 637-0787
mmedrano@oncologyanalytics.com